SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalculus Vct Regulatory News (CLC)

Share Price Information for Calculus Vct (CLC)

Share Price is delayed by 15 minutes
Get Live Data
53.25    0.00 (0.00%)
Bid:
48.00
Ask:
58.50
Spread: 10.50 (21.875%)
Market Cap: £51.93m
CLC Live PriceLast checked at - London Stock Exchange

Intraday Calculus Vct Share Chart

GM Statement

31 Aug 2017 11:20

RNS Number : 4452P
Calculus VCT PLC
31 August 2017
 

Calculus VCT plc

(the "Company")

 

GM Results

 

31 August 2017

 

This announcement is made by the Company in connection with the proposed merger of the Company with Neptune-Calculus Income and Growth VCT plc ("Neptune") (the "Merger"). The merger will be completed by way of a scheme of reconstruction of Neptune pursuant to section 110 of the Insolvency Act 1986 whereby Neptune will be placed in members' voluntary liquidation and all of its assets and liabilities transferred by its appointed liquidators to the Company in consideration for the issue of new shares in the Company to the shareholders of Neptune. Full details of the merger were contained in the Company's circular to shareholders ("Circular") dated 4 August 2017.

 

The Board is pleased to announce that at the general meeting of the Company held on 31 August 2017, all proposed resolutions set out in the Circular, including the resolution to approve the acquisition of the assets and liabilities of Neptune and to authorise the issue of new shares in the Company to the shareholders of Neptune, were duly passed on a show of hands. Proxy votes received in respect of each resolution were as follows:

 

 

Resolution 1 - Approval of the Merger

 

Votes

Number of Shares

 

Percentage of Votes Cast

For and Chairman's Discretion

1,173,581

85%

Against

213,115

15%

Withheld

0

0%

 

Resolution 2 - Authority to allot new Ordinary Shares pursuant to the Offer

 

Votes

Number of Shares

 

Percentage of Votes Cast

For and Chairman's Discretion

1,386,696

100%

Against

0

0%

Withheld

0

0%

 

Resolution 3 - Disapplication of pre-emption rights

 

Votes

Number of Shares

 

Percentage of Votes Cast

For and Chairman's Discretion

1,173,581

85%

Against

213,115

15%

Withheld

0

0%

 

Resolution 4 - Reduction of share premium account

 

Votes

Number of Shares

 

Percentage of Votes Cast

For and Chairman's Discretion

1,173,581

85%

Against

213,115

15%

Withheld

0

0%

 

Resolution 5 - Amendments to the Company's articles of association

 

Votes

Number of Shares

 

Percentage of Votes Cast

For and Chairman's Discretion

1,173,581

85%

Against

213,115

15%

Withheld

0

0%

 

Resolution 6 - Approval of amendments to investment management agreement with Calculus Capital Limited

 

Votes

Number of Shares

 

Percentage of Votes Cast

For and Chairman's Discretion

1,149,785

84%

Against

213,115

16%

Withheld

23,796

0%

 

 

A copy of the resolutions passed at the above meeting will shortly be available for inspection on both the Company's website (www.calculuscapital.com/calculus-vct-plc/) as well as at the National Storage Mechanism (www.morningstar.co.uk/uk/NSM).

 

Total Voting Rights

In conformity with the Disclosure Guidance and Transparency Rules, Calculus confirms that the Company's issued share capital consists of 8,825,947 Ordinary Shares with a nominal value of 1p each, with voting rights. The Company does not hold any shares in treasury and therefore, the total number of voting rights is 8,825,947 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Calculus Capital Limited

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
GMSLLFLITTILVID
Date   Source Headline
8th Sep 20201:01 pmRNSPublication of a Prospectus
8th Sep 202012:51 pmRNSPublication of a Prospectus
3rd Sep 20202:46 pmRNSIssue of Equity
31st Jul 202012:46 pmRNSDirector/ PDMR shareholding
3rd Jul 20204:42 pmRNSResult of AGM
3rd Jul 20204:09 pmRNSDirectorate Change
18th Jun 20204:45 pmRNSTransaction in Own Shares
17th Jun 20205:34 pmRNSNet Asset Value 31 May 2020
17th Jun 20205:07 pmRNSNet Asset Value 31 May 2020
27th May 20203:40 pmRNSAnnual Financial Report
21st May 20204:09 pmRNSDirector Declaration
3rd Apr 20204:15 pmRNSIssue of Equity
31st Mar 20202:18 pmRNSNet Asset Value(s) and Impact of Covid-19
19th Dec 20194:22 pmRNSNet Asset Value(s)
12th Dec 201911:29 amRNSIssue of Equity and Correction
18th Oct 20194:40 pmRNSHalf-year Report
24th Sep 20192:18 pmRNSPublication of a Prospectus
6th Sep 201911:22 amRNSIssue of Equity
4th Sep 20193:20 pmRNSNet Asset Value(s)
31st Jul 20192:48 pmRNSTransaction in Own Shares
4th Jul 20194:24 pmRNSResult of AGM
26th Jun 20192:25 pmRNSIssue of Equity
14th Jun 20199:52 amRNSNet Asset Value(s)
9th May 20195:49 pmRNSAnnual Financial Report - Replacement
9th May 20194:12 pmRNSAnnual Financial Report
5th Apr 20193:49 pmRNSIssue of Equity
28th Feb 201910:41 amRNSIssue of Equity
22nd Feb 20194:46 pmRNSNet Asset Value(s)
4th Feb 201910:02 amRNSDirectorate Change
24th Jan 201910:19 amRNSHolding(s) in Company
23rd Jan 201912:46 pmRNSIssue of Equity
16th Jan 20192:45 pmRNSNet Asset Value(s)
8th Jan 20193:49 pmRNSNet Asset Value(s)
18th Dec 201812:42 pmRNSDirector Declaration
13th Dec 20183:34 pmRNSDirectorate Change
6th Nov 201810:17 amRNSTransaction in Own Shares
23rd Oct 20184:32 pmRNSHalf-year Report
9th Oct 20183:21 pmRNSGM Statement
17th Sep 20184:33 pmRNSHolding(s) in Company
17th Sep 20184:33 pmRNSHolding(s) in Company
14th Sep 20187:00 amRNSPublication of a Prospectus
22nd Aug 20189:24 amRNSDirector Declaration
21st Aug 20184:54 pmRNSTransaction in Own Shares
16th Aug 20183:32 pmRNSNet Asset Value(s)
2nd Aug 20181:31 pmRNSIssue of Equity
19th Jul 20184:32 pmRNSNet Asset Value(s)
3rd Jul 201812:21 pmRNSResult of Meeting & Offer for subscription
19th Jun 20183:38 pmRNSNet Asset Value(s)
22nd May 20184:52 pmRNSDividend Declaration
17th May 20183:48 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.